Smith & Nephew, the FTSE 100 manufacturer of hip and knee replacements, has received a £7bn takeover approach from Johnson & Johnson, its US-based rival, I can reveal.
An indicative offer valuing Smith & Nephew (S&N), one of the world’s largest orthopaedics-makers, at more than 750p-a-share was tabled with the company several weeks before Christmas, I’m told.
The approach from Johnson & Johnson (J&J) was discussed by board members at S&N before being rejected on the basis that it substantially undervalued the company.
I understand that the American company has been evaluating whether to return with a higher offer although there’s no certainty that it will do so.
Looking beyond the spin of Big Pharma PR. But encouraging gossip. Come in and confide, you know you want to! “I’ll publish right or wrong. Fools are my theme, let satire be my song.” Email: jackfriday2011(at)hotmail.co.uk
Sunday, January 09, 2011
Exclusive: Smith & Nephew Received £7bn Bid Approach by Mark Kleinman | Sky News Blogs
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment